Dr Michael Collins MBChB FRACP PhD is a transplant nephrologist at the Royal Adelaide Hospital and a Clinical Senior Lecturer at the University of Adelaide. After completing a PhD in transplant immunology at the University of Adelaide, he has worked as a nephrologist and clinical researcher in Auckland, New Zealand, and Adelaide, South Australia. He proposed and is the co-lead investigator of the BEST-Fluids trial, a multi-centre, pragmatic trial of IV fluid therapy in kidney transplant recipients. This work was supported by the Jacquot Research Establishment Fellowship, in addition to funding from the Medical Research Future Fund (Australia), the New Zealand Health Research Council and the BEAT-CKD group of investigators. He is the Deputy Chair of the Australasian Kidney Trials Network Scientific Committee, and an active clinical trialist. His ongoing research focuses on designing and conducting clinical trials of interventions that will improve outcomes for kidney transplant recipients.